A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the highest dose of a ABI-007 that can be given
with cisplatin and 5-fluorouracil without causing intolerable side effects in patients with
advanced head and neck cancer.